ask="40.00"
ask_size="500"
average_daily_volume="223238"
bid="N/A"
bid_size="N/A"
book_value="3.79"
change="+0.17"
change_from_200_day_moving_average="4.39"
change_from_50_day_moving_average="1.96"
change_from_52_week_high="-2.60"
change_From_52_week_low="16.53"
change_in_percent="+0.56%"
close="30.65"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.07"
ebitda="-37.24M"
eps_estimate_current_year="-2.36"
eps_estimate_next_quarter="-0.54"
eps_estimate_next_year="-2.97"
ex_dividend_date="N/A"
float_shares="15981000"
high="31.72"
high_52_weeks="33.25"
last_trade_date="3/15/2017"
last_trade_price="30.65"
last_trade_size="7007"
last_trade_time="4:00pm"
low="28.71"
low_52_weeks="14.12"
market_capitalization="656.89M"
moving_average_200_day="26.26"
moving_average_50_day="28.69"
name="Aclaris Therapeutics
Inc."
notes="N/A"
one_year_target_price="38.17"
open="29.75"
pe_ratio="N/A"
peg_ratio="-0.22"
percent_change_from_200_day_moving_average="+16.71%"
percent_change_from_50_day_moving_average="+6.83%"
percent_change_from_52_week_high="-7.82%"
percent_change_from_52_week_low="+117.07%"
previous_close="30.48"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="8.05"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21432000"
short_ratio="6.77"
stock_exchange="NMS"
symbol="ACRS"
volume="372396"
weeks_range_52="14.12 - 33.25"
